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during Transcription
Amita Singh,1 Emanuel Compe,1 Nicolas Le May,1,* and Jean-Marc Egly1,*
Mutations in genes encoding the ERCC3 (XPB), ERCC2 (XPD), and GTF2H5 (p8 or TTD-A) subunits of the transcription and
DNA-repair factor TFIIH lead to three autosomal-recessive disorders: xeroderma pigmentosum (XP), XP associated with Cockayne
syndrome (XP/CS), and trichothiodystrophy (TTD). Although these diseases were originally associated with defects in DNA repair,
transcription deficiencies might be also implicated. By using retinoic acid receptor beta isoform 2 (RARB2) as a model in several
cells bearing mutations in genes encoding TFIIH subunits, we observed that (1) the recruitment of the TFIIH complex was altered
at the activated RARB2 promoter, (2) TFIIH participated in the recruitment of nucleotide excision repair (NER) factors during
transcription in a manner different from that observed during NER, and (3) the different TFIIH variants disturbed transcription
by having distinct consequences on post-translational modifications of histones, DNA-break induction, DNA demethylation, and
gene-loop formation. The transition from heterochromatin to euchromatin was disrupted depending on the variant, illustrating
the fact that TFIIH, by contributing to NER factor recruitment, orchestrates chromatin remodeling. The subtle transcriptional
differences found between various TFIIH variants thus participate in the phenotypic variability observed among XP, XP/CS, and
TTD individuals.Introduction
The evolutionarily conserved general transcription factor
IIH (TFIIH) plays a key role in maintaining genome stabil-
ity.1,2 Mammalian TFIIH comprises a core (containing the
six subunits ERCC3 [XPB], GTF2H1 [p62], GTF2H4 [p52],
GTF2H2 [p44], GTF2H3 [p34], and GTF2H5 [p8 or TTD-
A]) bridged by ERCC2 (XPD) to the CDK-activating kinase
(CAK) module (composed of the three subunits CDK7,
CCNH [cyclin H], and MNAT1 [MAT1]; Figure 1A). In addi-
tion to having a function in transcription, TFIIH is also
involved in the nucleotide excision repair (NER) pathway,
thus illustrating the important interplay between these
distinct processes.3,4 NER is responsible for the removal
of a variety of bulky DNA adducts, such as those induced
by UV irradiation, and is subdivided into two sub-path-
ways: global genome repair (GGR) is responsible for the
removal of DNA lesions from the whole genome, and tran-
scription-coupled repair (TCR) is responsible for the accel-
erated removal of lesions arising on the transcribed strand
of active genes.5,6 In GGR, the XPC-RAD23B complex rec-
ognizes the damage-induced DNA distortion, whereas in
TCR, RNA polymerase II (pol II) stalled in front of a lesion
promotes the recruitment of the TCR-specific proteins
ERCC6 (CSB) and ERCC8 (CSA). Both NER sub-pathways
then funnel through the TFIIH action that unwinds the
DNA via the ATPase and helicase activities of ERCC3 and
ERCC2, which are regulated by the GTF2H4-GTF2H5 and
GTF2H2 subunits, respectively. XPA and RPA are then re-
cruited to assist the expansion of the DNA bubble around1Genome Expression and Repair Team, Labellise´e Ligue contre le Cancer 2014, D
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(XPG) and ERCC4 (XPF). ERCC5 and ERCC4 then generate
cuts in the 30 and 50 sides of the lesion, respectively,
thereby removing the damaged oligonucleotide before
the re-synthesis machinery fills the DNA gap. During tran-
scription of protein-coding genes, TFIIH is involved via its
ERCC3 subunit in the opening of the promoter,7,8 whereas
its CDK7 kinase phosphorylates serines 5 and 7 of the
C-terminal domain (CTD) of pol II, as well as others activa-
tors.9,10 Interestingly, NER factors (XPC, ERCC6, XPA,
ERCC5, and ERCC4) have been found to also be involved
in the regulation of gene expression.11–13 However, it re-
mains to be established whether TFIIH influences the
recruitment and the function of NER factors at the pro-
moter of activated genes for chromatin remodeling and
accurate transcription.
The importance of TFIIH and its relationship with the
other NER factors are highlighted by the existence of hu-
man genetic disorders with a broad range of clinical fea-
tures (Table 1).14–20 Indeed, mutations in excision repair
complementation group 3 (ERCC3 [MIM 133510]), exci-
sion repair complementation group 2 (ERCC2 [MIM
126340]), and general transcription factor IIH polypeptide
5 (GTF2H5 [MIM 608780]) cause three distinct auto-
somal-recessive disorders: xeroderma pigmentosum (XP
[MIM 278730]), XP associated with Cockayne syndrome
(XP/CS [MIM 610651]), and trichothiodystrophy (TTD
[MIM 610675]), respectively.21,22 XP is characterized by
numerous skin abnormalities ranging from excessive freck-
ling and ichthyosis to multiple skin cancers, the frequencyepartment of Functional Genomics and Cancer, Institut de Ge´ne´tique et de
, INSERM, Universite´ de Strasbourg, BP 163, 67404 Illkirch Cedex, CU Stras-
y of Human Genetics. All rights reserved.
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Figure 1. Schematic Representation of TFIIH
(A) The CAK sub-complex (in blue) is bridged to the core TFIIH (in
red) by the ERCC2 (XPD) helicase (in green).
(B) Variants of the ERCC3 (XPB), ERCC2 (XPD), and GTF2H5
(TTD-A) subunits are indicated. Black squares indicate the helicase
motifs (I–VI). NTD stands for N-terminal domain.of which is about 2,000-fold greater than that in normal in-
dividuals. In addition to having hyper-photosensitivity,
XP individuals display a progressive neurological degener-
ation.23 XP/CS individuals display a combination of the
cutaneous abnormalities found in XP and the severe
neonatal later onset of neurological and developmental
anomalies typical of CS. The typical hallmark of TTD is
sulfur-deficient brittle hair, caused by a greatly reduced
content of cysteine-rich matrix proteins in the hair shafts.
Intellectual disability and ichthyosis also characterize TTD
individuals,24 and some of them are sensitive to sunlight
without any unusual pigmentation changes and severe
skin lesions or cancer.
Accumulating evidence suggests that the clinical fea-
tures of these three disorders cannot be exclusively ex-
plained by defects in DNA repair and might also involve
transcription deficiencies25 (Table 1).14–20 In this study,
we intend to understand how mutations in ERCC3,
ERCC2, and GTF2H5 result in impairment of gene expres-
sion in order to provide explanations for the large and
diverse range of clinical features associated with these mu-
tations. Knowing the close connections between TFIIH
and NER factors in the removal of DNA damage,26 we
have investigated the consequences of ERCC3, ERCC2,The Americand GTF2H5 variants on the recruitment of the NER fac-
tors and their roles in the various steps that lead to accurate
RNA synthesis, including histone post-translational modi-
fications (PTMs), DNA breaks, DNA demethylation, and
gene-loop formation. In addition to improving our under-
standing of the cascade of events that drive RNA synthesis,
such a systematic approach could help to determine
transcriptional default hallmarks that molecularly define
different genetic disorders.Material and Methods
Cell Lines, Culture Conditions, and Transfection
Wild-type (WT)-ERCC3 (XPB) cells, ERCC3-p.Phe99Ser cells, and
ERCC3-p.Thr119Pro cells are SV40-transformed human fibroblasts
(XPCS2BASV) expressing WT His-ERCC3-HA,27 ERCC3 c.296T>C
(RefSeq accession number NM_000122.1), and ERCC3 c.355A>C,
respectively.28 GTF2H5 (p8 or TTD-A) cells are SV40-transformed
human fibroblasts (TTD1Br-SV) expressing GTF2H5 c.[62T>C];
[116C>T], p.[Leu21Pro];[Arg56*] (RefSeq NM_207118.2).16 WT-
GTF2H5 cells (TTD1Br-SV þ TTDA-GFP and TTD1Br-SV þ TTDA-
HA) are rescued TTDBr1-SV cells with pEGFP-N1-TTDA and
pCDNA3-HA-TFB5 vectors that stably express GTF2H5-GFP and
GTF2H5-HA, respectively.29,30 WT-ERCC2 (XPD) cells (GM637) are
SV40-transformed human fibroblasts from a normal 18-year-old
female. ERCC2-p.Gly602Asp cells (XPCS2),18 ERCC2-p.Arg112His
cells (TTD8PV),16 ERCC2-p.Arg683Trp cells (XP135LO),18 and
ERCC2-p.Arg722Trp cells (TTD1BEL)19 are human primary fibro-
blasts expressing ERCC2 c.1805G>A (RefSeq NM_000400.3),
ERCC2 c.335G>A, ERCC2 c.2047C>T, and ERCC2 c.2164C>T,
respectively. Cells were incubated with phenol-red-free medium
containing charcoal-treated fetal calf serum and 40 mg/ml genta-
micin. Cells were treated with 10 mM of all-trans retinoic acid
(t-RA,MPBiomedicals). ERCC2-p.Arg112His, ERCC2-p.Gly602Asp,
ERCC2-p.Arg683Trp, and ERCC2-p.Arg722Trp cells were tran-
siently transfected with the X-tremeGENE HP DNA transfection
reagent (Roche) 48 hr before the t-RA treatment with WT pEGFP-
ERCC2.
Antibodies
Mousemonoclonal antibodies toward ERCC3 (1B3), ERCC2 (2F6),
GTF2H2 (p44, 1H5), retinoic acid receptor alpha (RARa, 9A6),
XPA (1E11), ERCC5 (XPG, 1B5), and pol II (7C2) were produced
by the Institut de Ge´ne´tique et de Biologie Mole´culaire et Cellu-
laire. CDK7 (C-19), general transcription factor IIB (GTF2B [TFIIB],
C-18), ERCC4 (XPF, H-300), and BIOTIN (33) antibodies were pur-
chased from Santa-Cruz Biotechnology. CTCF (ab70303) and RNA
pol II ser5P (61085) antibodies were purchased from Abcam and
Active Motif, respectively. H3K4me2 (9726), H3K9me2 (9753),
andH3K9Ac (9671) antibodies were purchased fromCell Signaling
Technology.
Reverse Transcriptase and qPCR
Total RNAs were isolated with the GenElute Mammalian Total
RNA Miniprep Kit (Sigma) and reverse transcribed with Super-
Script II Reverse Transcriptase (Invitrogen). qPCRs were performed
with the QuantiTect SYBR Green PCR Kit (QIAGEN) and the
LightCycler 480 apparatus (Roche). The primer sequences for ret-
inoic acid receptor beta isoform 2 (RARB2 [MIM 180220]) and glyc-
eraldehyde 3-phosphate dehydrogenase (GAPDH [MIM 138400])an Journal of Human Genetics 96, 194–207, February 5, 2015 195
Table 1. ERCC3, ERCC2, and GTF2H5 Mutations and the Related Clinical XP, XP/CS, and TTD Phenotypes
Gene
Mutation
Protein
Variant Syndrome Individual Clinical Features Reference
ERCC3
c.296T>C
ERCC3
p.Phe99Ser
XP/CS male severe sunburn at 6 weeks of age and later hyper-pigmentation,
but no evidence of any malignancy; CS neurological anomalies
including cerebellar atrophy, sclerosis of sutures, neuron
demyelination, and some hearing difficulties; development of
sexual anomalies with age
Scott et al.14
ERCC3
c.355A>C
ERCC3
p.Thr119Pro
TTD male congenital ichthyosis (collodion baby); hair with tiger-tail
pattern; moderate skin photosensitivity; mild learning disability
Weeda et al.15
GTF2H5
c.[62T>C];
[116C>T]
GTF2H5
p.[Leu21Pro];
[Arg56*]
TTD male congenital ichthyosis (collodion baby); moderate skin
photosensitivity, but no skin cancer; developmental delay,
asthmatic attacks, and short stature; severe mental retardation
Stefanini et al.16
ERCC2
c.335G>A
ERCC2
p.Arg112His
TTD male moderate skin photosensitivity, but no skin cancer; sulfur-
deficient brittle hair and nails; delayed puberty and short
stature; neurological anomalies including axial hypotonia and
reduced motor coordination
Stefanini et al.17
ERCC2
c.1805G>A
ERCC2
p.Gly602Asp
XP/CS male high skin photosensitivity and skin cancer at 2 years of age; CS
neurological anomalies; progeroid features
Takayama et al.18
ERCC2
c.2047C>T
ERCC2
p.Arg683Trp
XP male high skin photosensitivity and skin cancers; moderate mental
retardation
Broughton et al.19
ERCC2
c.2164C>T
ERCC2
p.Arg722Trp
TTD male high skin photosensitivity, but no skin cancer; sulfur-deficient
brittle hair and nails; severe physical and mental retardation
Taylor et al.20are listed in Table S1. RARB2 mRNA levels were normalized to
GAPDH.
Chromatin Immunoprecipitation and BIOTIN-ChIP
Assays
Cells were cross-linked at room temperature (RT) for 10 min with
1% formaldehyde. Chromatin was prepared and sonicated on
ice for 30 min with a Bioruptor (Diagenode) as previously
described.12 Samples were immunoprecipitated with antibodies
at 4C overnight, and protein G Sepharose beads (Upstate) were
added, incubated for 4 hr at 4C, and sequentially washed.
Protein-DNA complexes were eluted and de-cross-linked. DNA
fragments were purified with the QIAquick PCR Purification Kit
(QIAGEN) and analyzed by qPCR with a set of primers targeting
the promoter and terminator regions of RARB2 (Table S1).
In parallel, cross-linked cells were permeabilized with cytonin
(Trevigen) for 30 min at RT. After extensive washes with PBS, a ter-
minal deoxynucleotidyl transferase (TdT) reaction was performed
with Biotin-16-dUTP (Roche) and 60 units of recombinant enzyme
rTdT (Promega). The resulting samples were next sonicated and
immunoprecipitated with anti-Biotin antibodies and treated as
described in the chromatin immunoprecipitation (ChIP) assay.
The purified DNA fragments were analyzed by qPCR with the pre-
viously described primers (Table S1).
Unmethylated DNA Immunoprecipitation Assays
Genomic DNA was extracted with the GenElute Mammalian
Genomic DNA Miniprep Kit (Sigma). Loss of 5-methylcytosine
(5mC) at the promoter and terminator regions of RARB2 was
measured by digestion of genomic DNA (2 mg) with 10 units of
MseI (Fermentas) and with the UnMethylcollector Kit (Active
Motif). The unmethylated DNA immunoprecipitation (unMeDIP)
kit is based on the affinity of the three zinc-coordinating CXXC
domains that specifically bind nonmethylated CpG sites. The re-
sulting samples were selected with magnetic beads conjugated
with CXXC domains, extensively washed, and analyzed by qPCR.196 The American Journal of Human Genetics 96, 194–207, FebruaryQuantitative Chromosome Conformation Capture
The quantitative chromosome conformation capture (q3C) assay
was performed as previously described.31 Cells were cross-linked
at RT for 10 min with 2% formaldehyde. Cross-linked chromatin
was digested in the appropriate restriction buffer with 400 units
of HindIII. The digestion was stopped after overnight incubation
at 37C, diluted in ligation buffer, and incubated with the highly
concentrated T4 DNA ligase (Roche) for 4 hr at 16C. The cross-
linking was heat reversed, and DNA fragments were purified.
Undigested DNA and digested DNA without the ligation step
were used as negative controls. Moreover, as an internal positive
control, we used the endogenous ERCC3, which has been reported
to adopt the same spatial conformation in different tissues.31 All
q3C results were normalized by data from ERCC3 analysis, which
controlled for changes in nuclear size, chromatin density, and
cross-linking efficiency. Primers and probes were designed as fol-
lows: a universal sequence-specific Taqman probe and correspond-
ing reverse primer on a fixed restriction fragment (Ter or M1) were
used in combination with different forward primers specific to the
other restriction fragments (see Figure 4, upper panel). q3C tem-
plates (200 ng) were used for the Taqman PCR reaction with the
universal PCR Master Mix and the Lightcycler 480 apparatus
from Roche.Construction of Baculoviruses and Purification of
Complexes
Baculoviruses overexpressing the FLAG-ERCC3, FLAG-ERCC2,
GTF2H1 (p62), GTF2H4 (p52), GTF2H2, GTF2H3 (p34), FLAG-
CDK7, CCNH (cyclin H), MNAT1 (MAT1), and GTF2H5 subunits
of TFIIH were produced as previously described.32 The cDNAs en-
coding altered FLAG-ERCC3 and FLAG-ERCC2 were obtained by
PCR-site-directed mutagenesis. The resulting vectors were recom-
bined with baculovirus DNA (BD BaculoGold, Pharmingen). The
recombinant viruses were purified from isolated plaques, and viral
stocks were prepared by three-step growth amplification.5, 2015
We infected Sf21 insect cells with the different baculoviruses in
order to separately obtain core-IIH (with or without an ERCC3
variant), CAK, and ERCC2 (with or without a variant). The
different whole-cell extracts were incubated for 4 hr at 4C with
anti-M2-FLAG antibody bound to agarose beads. After extensive
washings, the immunoprecipitated fractions were eluted. The
recombinant TFIIH was made by a mixture of purified core-IIH,
CAK, and ERCC2, allowing the preparation of the different TFIIH
complexes containing either ERCC2 or ERCC3 variants.In Vitro Transcription Assays
Run-off transcription assays were performed with recombinant
GTF2B, TFIIE, TFIIF, TBP, endogenous pol II, and the different
TFIIH complexes (recombinant IIHs) as previously described.32
Pol II phosphorylation was carried out as a classical run-off tran-
scription assay as previously described.33 Hypo-phosphorylated
(IIA) and hyper-phosphorylated (IIO) forms of pol II were resolved
by SDS-PAGE and detected with a monoclonal antibody (7C2).Results
Mutations in ERCC2 and ERCC3 Compromise the
Formation of the Transactivation Complex
To determine the transcriptional defects due to the muta-
tions in ERCC3, ERCC2, and GTF2H5, we analyzed cells
derived from XP, XP/CS, and TTD individuals bearing
different mutations as indicated (Table 1; Figure 1B). We
used RARB2 as a model to investigate the transcription pro-
cess. A few hours after t-RA treatment of these mutated
cells, we observed that their patterns of RARB2 mRNA
synthesis were different from those of the respective WT-
ERCC3 (XPB), WT-ERCC2 (XPD), and WT-GTF2H5 (p8 or
TTD-A) cells (Figures 2A1–2J1). The amount of RARB2
mRNA was significantly lower for ERCC3-p.Phe99Ser and
ERCC3-p.Thr119Pro cells than for WT-ERCC3 cells, which
peaked at 8 hr post-treatment (Figures 2A1–2C1).
Compared to the cells rescued with an overexpressing
WT ERCC2, the four cell lines bearing mutations in
ERCC2 showed similarly reduced RARB2 induction (Figures
2F1–2J1). Compared to rescued cells, GTF2H5 cells did not
show a reduction of the RARB2 mRNA level (Figures 2D1
and 2E1).
We next performed ChIP assays to evaluate the dynamic
recruitment of pol II partners at the RARB2 promoter over
time.We observed a concomitant recruitment of RARa, pol
II, and GTF2B at 8 hr after t-RA treatment in WT-ERCC3,
WT-ERCC2, and WT-GTF2H5 cells (Figures 2A2, D2, and
F2, respectively). At this time, TFIIH was also recruited,
as seen by the presence of its ERCC3, ERCC2, GTF2H2
(p44), and CDK7 subunits (Figures 2A3, 2D3, and 2F3).
We also detected the simultaneous presence of XPA,
ERCC5 (XPG), and ERCC4 (XPF) (Figures 2A4, 2D4,
and 2F4).
Each mutation in ERCC3, ERCC2, and GTF2H5 led to
different and specific deregulation of recruitment of the
components of the transactivation complex at both the
promoter and the terminator (Figure 2; Figure S1).WhereasThe AmericRARa was detected at early time points in ERCC3-
p.Phe99Ser cells, pol II and GTF2B only accumulated at
the promoter after 1 hr of t-RA induction (Figure 2B2).
We also noticed a non-concomitant recruitment of
the TFIIH subunits and NER factors. Whereas ERCC5
was recruited at 3 hr in ERCC3-p.Phe99Ser cells, XPA
and ERCC4 were not detected over a 12-hr period
(Figure 2B4). In ERCC3-p.Thr119Pro cells, RARa, pol II,
and GTF2B were detected at the promoter around the
3-hr mark (Figure 2C2). The ERCC3 subunit was found at
the promoter at 1 hr, whereas the ERCC2, GTF2H2, and
CDK7 subunits were detected later (Figure 2C3). Similarly,
XPA arrival (1 hr) preceded ERCC5 (6 hr), whereas ERCC4
was not detected (Figure 2C4). In cells bearing mutations
in GTF2H5, we observed a concomitant recruitment of
TFIIH subunits and NER factors with the transcriptional
machinery at 8 hr after t-RA treatment; a similar result
was observed with the corresponding rescued cell types
(Figures 2D2–2D4 and 2E2–2E4).
We next focused on the cells bearing mutations in
ERCC2 and resulting in three different phenotypes
(Figure 1B; Table 1). In ERCC2-p.Arg112His cells, the
recruitment of transcription and NER factors was tempo-
rarily correlated. All these factors were found in a second
recruitment cycle that peaked at 8 hr, remained present
until 12 hr after t-RA treatment, and paralleled RARB2
mRNA induction (Figures 2G1 and 2G2–2G4). In ERCC2-
p.Gly602Asp cells, the recruitment pattern at 1 hr and
6 hr after t-RA treatment of pol II, GTF2B, TFIIH, and
NER factors at the promoter was comparable to that
in WT-ERCC2 cells (Figures 2H2–2H4). The ERCC2
p.Gly602Asp variant, which affects the helicase motif V,
does not seem to disturb TFIIH architecture.32 In ERCC2-
p.Arg683Trp cells, the recruitment of TFIIH and NER fac-
tors was highly deregulated at early time points (Figures
2I2–2I4). At 8 hr, only pol II, GTF2B, and XPA were de-
tected. In ERCC2-p.Arg722Trp cells, in which the aberra-
tion is located in the C-terminal unfolded domain of
ERCC2, we observed the recruitment of both transcription
and NER factors at 8 hr (Figures 2J2–2J4); a much higher
and continuous accumulation of pol II, GTF2B, and some
of the TFIIH subunits also occurred at 12 hr. In these cells,
the ERCC2 p.Arg683Trp and p.Arg722Trp variants weaken
the interaction with the GTF2H2 subunit and conse-
quently destabilize the architecture of TFIIH.32
All together, our data suggest that mutations in ERCC3
and ERCC2 disturb RARB2 activation by impeding the for-
mation of the pre-initiation complex at the promoter.
Although the dysregulation was different depending on
the mutation, we noticed a compromised integrity of the
TFIIH complex and, in some cases, the absence of NER
factors at the activated promoter.
Mutations in Genes Encoding TFIIH Subunits Affect
Chromatin Remodeling
Previous works have underlined the sequential recruit-
ment of the transcription and NER components at thean Journal of Human Genetics 96, 194–207, February 5, 2015 197
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Figure 2. RARB2mRNA Expression and Transcriptional-Machinery Recruitment on the RARB2 Promoter Are Disturbed in Cells Bearing
Mutations in Genes Encoding TFIIH Subunits
(A1–J1) Relative RARB2 mRNA expression monitored by qPCR over time from t-RA-treated (1) WT-ERCC3, ERCC3-p.Phe99Ser, and
ERCC3-p.Thr119Pro cells, which are SV40-transformed human fibroblasts (XPCS2BASV) expressing WT His-ERCC3-HA,27 ERCC3
(legend continued on next page)
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promoter of activated genes and their role in bringing
about chromatin modifications, e.g., histone PTMs, DNA
breaks, and DNA demethylation.11,13 Among the histone
hallmarks characterizing the chromatin status, we have
focused and compared euchromatin histone PTMs (acety-
lated lysine 9 histone H3 [H3K9Ac] and dimethylated
lysine 4 histone H3 [H3K4me2]) to the heterochromatin
mark (dimethylated lysine 9 histone H3 [H3K9me2]) previ-
ously observed at the RARB2 promoter.12,34
In WT-ERCC3 and WT-ERCC2 cells treated with t-RA,
ChIP showed the characteristic histone PTM signature of
gene activation (increased H3K9ac and H3K4me2 and
decreased H3K9me2; Figures 3A1 and 3F1), correlating
with the RARB2 mRNA induction peak at 8 hr. In all
mutated cells tested so far (Figures 3B1, 3C1, and 3G1–
3J1), we observed a persistence of active histone PTMs
around the RARB2 promoter. As an example, in ERCC2-
p.Arg112His cells, in which the transcription and NER fac-
tors were shown to be recruited at the promoter by 8 hr
post-treatment, H3K9me3 remained low; however, we
noticed high acetylation and methylation of H3K9 and
H3K4, respectively (Figure 2G1). In both GTF2H5 and
rescued cells, H3K9me2 was hardly detectable, whereas
H3K9ac and H3K4me2 were visible (Figure 3D1 and E1).
The formation of transient DNAbreaks upon gene activa-
tion is linked to endonucleases ERCC5 and ERCC4 and has
previously been reported at the RARB2 promoter.35,36 We
thus evaluated the formation of such DNA breaks in the
cells bearing mutations in ERCC3, ERCC2, and GTF2H5
by performing a BioChIP assay that measured the incorpo-
ration of biotinylated dUTP within broken DNA. We
observed a concomitant increase in DNA cleavage at both
the promoter and the terminator of all WT cells upon t-
RA activation (Figures 3A2, 3D2, and 3F2; Figure S2). In
these cells, we noticed a parallel among the presence of
ERCC5, ERCC4, and DNA breaks at both promoters and
terminators. Except for in GTF2H5, ERCC2-p.Arg112His,
ERCC2-p.Arg722Trp, and ERCC3-p.Thr119Pro cells
(although to a much lower extent) in which ERCC5 and
ERCC4 were still detected (Figures 3C2, 3E2, 3G2, and
3J2), a significant induction of DNA breaks near the
RARB2 promoter was not detected in mutated cell lines
(Figures 3B2, 3H2, and 3I2). It should be noted that the
DNA breaks were observed around the RARB2 terminator
in WT and GTF2H5 cells, whereas in all the other mutated
cell lines, no DNA breaks were detected (Figure S2).c.296T>C, and ERCC3 c.355A>C, respectively; (2) GTF2H5 (p8 or TTD
SV) expressing GTF2H5 c.[62T>C];[116C>T], p.[Leu21Pro];[Arg56*];
TTD1Br-SV cells stably expressing GTF2H5-HA; and (4) WT-ERCC2
p.Arg112His cells (TTD8PV), ERCC2-p.Arg683Trp cells (XP135LO),18
mary fibroblasts expressingWT ERCC2, ERCC2 c.1805G>A, ERCC2 c
Red curves show the mRNA expression of RARB2 in the parental cell
WT cell line (GM637). Blue curves show mRNA expression of RARB2
cells overexpressing WT GFP-ERCC2 (ERCC2 p.Arg112His, ERCC2 p
bars represent the SD of three independent experiments.
(A2–J4) ChIP monitoring of the t-RA-dependent recruitment of RA
subunits of TFIIH (A3–J3) and XPA, ERCC5, ERCC4, and CTCF (A4–
of at least two independent experiments. Values are expressed as the
The AmericStudies have documented a relationship between ERCC5
and DNA demethylation upon transcription.11 Using an
unMeDIP approach, we measured the removal of 5mC at
the RARB2 promoter. We found that DNA demethylation
occurred at the promoter by 8 hr after t-RA treatment
and perfectly paralleled the recruitment of the entire
transcription machinery in the three WT cell lines (Figures
3A3, 3D3, and 3F3). On the contrary, there was a complete
lack of DNA demethylation in all cells bearing mutations
in ERCC2 and ERCC3 (Figures 3B3, 3C3, and 3G3–3J3),
but not in GTF2H5 cells (Figure 3E3).
Taken together, the above data strongly support an
involvement of TFIIH in chromatin remodeling, including
the histone PTMs, the formation of DNA breaks, and active
DNA demethylation.
Mutations in Genes Encoding TFIIH Subunits Affect
Gene Loop Formation
The detection of the basal transcription machinery
together with the NER factors at both the promoter and
the terminator of RARB2 has previously been correlated
with a chromatin-loop formation mediated by the
CCCTC-binding factor (CTCF) chromatin organizer.35
Such loop formation was shown to parallel DNA demethy-
lation and DNA breaks at both regions. We performed q3C
assays to analyze the interactions between the promoter
and the terminator, as well as intronic (M1), upstream
(65 kb), and downstream (þ323 kb) regions of RARB2
(Figure 4, upper scheme). Using the terminator and M1
as bait, we observed that the promoter specifically and
significantly interacted with the terminator by 8 hr in
t-RA-treated WT cells (Figures 4A, 4D, and 4F), paralleling
the recruitment of the entire transcriptional apparatus to
both regions (Figure 2; Figure S1). By contrast, in all cells
bearing mutations in genes encoding TFIIH subunits,
including GTF2H5 cells, no significant increase in the
frequency of terminator-promoter interactions occurred
upon RARB2 transactivation (Figures 4B–4J). In addition,
we also observed that the absence of loop formation
correlated with the absence or delayed recruitment of
CTCF at both the promoter and the terminator of RARB2
(Figures 2B4, 2C4, 2G4, 2H4, and 2J4; Figure S1). In
GTF2H5 cells, we did not observe an increase in the
interaction frequency between the terminator and the
promoter upon transcription, even though there were no
perturbations in recruitment of transcriptional or NER-A) cells, which are SV40-transformed human fibroblasts (TTD1Br-
(3) WT-GTF2H5 cells (TTD1Br-SV þ TTDA-HA), which are rescued
(XPD) cells (GM637), ERCC2-p.Gly602Asp cells (XPCS2), ERCC2-
and ERCC2-p.Arg722Trp cells (TTD1BEL), which are human pri-
.335G>A, ERCC2 c.2047C>T, and ERCC2 c.2164C>T, respectively.
s, including cells bearing mutations in ERCC2 and ERCC3 and the
in the rescued cells (expressing WT ERCC3 and WT GTF2H5) and
.Gly602Asp, ERCC2 p.Arg683Trp, and ERCC2 p.Arg722Trp). Error
Ra, pol II, GTF2B (A2–J2), ERCC3, ERCC2, GTF2H2, and CDK7
J4) on the RARB2 promoter. Each series of ChIP is representative
percentage of the input. Error bars represent the SD.
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Figure 3. Mutations in Genes Encoding TFIIH Subunits Disrupt Histone PTMs, DNA Breaks, and Active DNA Demethylation on the
RARB2 Promoter
(A1–J1) ChIP monitoring of the t-RA-dependent presence of H3K4me2, H3K9me2, and H3K9ac on the RARB2 promoter over time in all
the mentioned cell lines. Each series of ChIP is representative of at least two independent experiments.
(A2–J2) Detection of DNA breaks at the RARB2 promoter at 0 hr and at either 6 or 8 hr after t-RA treatment (depending on the timing of
the RNA expression peak; see shadowed areas in Figure 2). Each series of BioChIP is representative of three independent experiments, and
values are expressed as the percentage of the input. Error bars represent the SD.
(A3–J3) UnMeDIP experiments. Samples containing unmethylatedDNA on the RARB2 promoter were analyzed by qPCR. Each series of un-
MeDIP is representativeof two independent experiments, andvalues are expressed as thepercentageof the input. Errorbars represent theSD.machinery, nor of other tested chromatin-remodeling
events (Figure 4E). No specific interactions were observed
between the intronicM1 bait and the promoter or between
all the other analyzed fragments upon t-RA treatment
(Figure S3).
By impeding the recruitment of NER factors at the acti-
vated RARB2 promoter, TFIIH variants further disturbed200 The American Journal of Human Genetics 96, 194–207, Februarythe chromatin-loop formation required for optimal gene
expression.
Mutations in Genes Encoding TFIIH Subunits Impair
Some of Its Enzymatic Activities
We next addressed the contribution of ERCC3 and
ERCC2 activities to the formation of an accurate5, 2015
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Figure 4. TFIIH Is Involved in RARB2-Loop Formation
(Upper panel) Schematic representation of the primers used in q3C. One primer was designed at the RARB2 termination region (Ter) for
investigating the associations between the different elements, including upstream (65 kb), promoter (Pro), intronic (M1), and down-
stream (þ323 kb) regions as indicated by the black arrows.
(A–J) q3C assays were performed with cross-linked and HindIII-digested chromatin from all cells as indicated at 0 hr and at either 6 or
8 hr after t-RA treatment depending on the timing of the RNA expression peak (see shadowed areas in Figure 2). The bar chart (y axis)
shows the PCR product enrichment (%) normalized to the enrichment within human ERCC3. Each PCR was performed at least three
times. Signals were normalized to the total amount of DNA used andwere estimated with an amplicon located within a HindIII fragment
in RARB2. Error bars represent the SD.transcription-initiation complex, a prerequisite for
optimal RNA synthesis. We first generated recombinant
IIH6 (rIIH6, the core TFIIH containing GTF2H1, GTF2H4,
GTF2H2, GTF2H3, GTF2H5, and either WT or altered
ERCC3), WT or altered ERCC2, and CAK. These rIIH6
sub-complexes were added to an in vitro transcription
assay containing the adenoviral major late promoter
(run-off of 309 nt), all the basal transcription factors, and
pol II,32 along with CAK and ERCC2, either alone or in
combination. When added to the transcription assay con-
taining all the factors (including the ERCC2-CAK sub-com-
plex), ERCC3-p.Phe99Ser rIIH6 exhibited a much weaker
basal transcription activity than did WT-ERCC3 rIIH6
and ERCC3-p.Thr119Pro rIIH6 (Figure 5A). The addition
of CAK together with WT ERCC2 and ERCC3-p.Phe99Ser
rIIH6 did not improve RNA synthesis (lanes 5–7), contrary
to what occurred with WT-ERCC3 rIIH6 and ERCC3-
p.Thr119Pro rIIH6, which absolutely required the CAK
sub-complex for optimal RNA synthesis (lanes 1–3 and
8–10). Because the variant weakens the contact with the
GTF2H4 regulatory subunit within TFIIH,37 it results in aThe Americdefect in the unwinding of the RARB2 promoter by
ERCC3 and a defect in RNA synthesis. Interestingly, we
also noticed that the absence of WT ERCC2 resulted in
very weak RNA synthesis (lane 4 in Figure 5A and lanes 1
and 2 in Figure 5B). Because the ERCC2-GTF2H2 interac-
tion allows the anchoring of CAK to the core TFIIH,38
we next investigated the transcription activity of TFIIHs
containing ERCC2 variants. The addition of CAK and
increasing amounts of WT ERCC2 to our transcription
assay, which already contained WT rIIH6, stimulated
RNA synthesis (lanes 3 and 4 in Figure 5B); this was also
observed in the presence of ERCC2 p.Arg112His or
ERCC2 p.Gly602Asp (lanes 5–8). On the contrary, when
either ERCC2 p.Arg683Trp or ERCC2 p.Arg722Trp was
added, no significant increase in RNA synthesis was
observed (lanes 9–12).
We then investigated the impact of CAK on the
phosphorylation status of pol II during a classical run-
off transcription experiment (see Material and Methods;
Figure 5C). We observed that the hyper-phosphorylated
form of pol II (IIO) was prevalent in the presence of WTan Journal of Human Genetics 96, 194–207, February 5, 2015 201
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Figure 5. Effect of the TFIIH Alterations
during In Vitro RNA Synthesis and Pol II
Phosphorylation
(A) In vitro transcription assays with rIIH6
including WT ERCC3, ERCC3 p.Phe99Ser,
or ERCC3 p.Thr119Pro. When indicated
(þ), these rIIH6were incubated either alone
or in combinationwithERCC2and/orCAK.
(B) WT rIIH6 was incubated either alone or
in association with CAK and WT ERCC2,
ERCC2 p.Arg112His, ERCC2 p.Gly602Asp,
ERCC2 p.Arg683Trp, or ERCC2
p.Arg722Trp as indicated. The size (309
nt) of the transcript is indicated on the
right side of each panel.
(C) Phosphorylation of pol II during
in vitro transcription assays in the presence
of WT rIIH6, CAK, and increasing amounts
of ERCC2 p.Arg112His, ERCC2
p.Gly602Asp, ERCC2 p.Arg683Trp, and
ERCC2 p.Arg722Trp as indicated. Arrows
indicate hypo-phosphorylated (IIA) and
hyper-phosphorylated (IIO) forms of pol II.
(D) ChIP monitoring the t-RA-dependent
occupancy of the serine 5 phosphorylated
pol II on the RARB2 promoter from the
different indicated cells. Each series of
ChIP is representative of at least two inde-
pendent experiments. Values are expressed
as the percentage of the input. Error bars
represent the SD.ERCC2, ERCC2 p.Arg112His, or ERCC2 p.Gly602Asp
(lanes 2–7) and paralleled the increase in RNA synthesis
(Figure 5B, lanes 3–8). On the contrary, in the presence
of ERCC2 p.Arg683Trp or ERCC2 p.Arg722Trp, which is
deficient in stimulating RNA synthesis (Figure 5B, lanes 9–
12), pol II was not hyper-phosphorylated (Figure 5C, lanes
8–11). Moreover, ChIP experiments demonstrated that in
WT cells—as well as in GTF2H5, ERCC3-p.Thr119Pro,
ERCC2-p.Arg112His, and ERCC2-p.Gly602Asp cells—
phosphorylated pol II was detected at the RARB2 promoter
(Figures 5D1 and 5D3–5D8). On the contrary, in ERCC3-202 The American Journal of Human Genetics 96, 194–207, February 5, 2015p.Phe99Ser, ERCC2-p.Arg683Trp, and
ERCC2-p.Arg722Trp cells, phosphory-
lated pol II was not detected
(Figure 5D2, 5D9, and 5D10). The ef-
fects of the ERCC2 variants on pol II
phosphorylation were thus similar in
both in vitro and ex vivo contexts.
All together, the above data suggest
that the pol II phosphorylation de-
fects might contribute to the gene-
expression deregulation observed in
some cells bearing mutations in
ERCC3 and ERCC2.
Discussion
After the assembly of the pre-initia-
tion machinery (including TFIIA,GTF2B, TFIID, TFIIE, TFIIF, and RNA pol II), TFIIH unwinds
the DNA around the proximal promoter through its
ERCC3 (XPB) helicase subunit7 and phosphorylates the
CTD of the largest subunit of pol II via its CDK7 ki-
nase,9,39 allowing promoter escape and RNA elonga-
tion.40 In addition to regulating pol II, TFIIH regulates
other components of the transcription machinery (such
as nuclear receptors).41–43 Conversely, some of them—
including TFIIE, ERCC5 (XPG), and the Mediator com-
plex—regulate the activity of TFIIH, highlighting the
pivotal role played by this complex in transcription.44–47
ND ND ND
-
Figure 6. Mutations in Genes Encoding
TFIIH Subunits Specifically Disrupt Tran-
scription
(Upper panel) Upon t-RA ligand induction,
the transactivation complex is formed
once RARa and RXR targets its responsive
element; co-activators and the Mediator
complex are assembled at the RARB2
promoter together with the pre-initiation
complex. NER factors (XPC, ERCC6 [CSB],
XPA, ERCC5 [XPG], and ERCC4 [XPF]) are
then sequentially recruited and regulate
RNA synthesis by participating in chro-
matin remodeling. These include histone
PTMs, induction of DNA breaks, and active
demethylation of 5mC, all together neces-
sary for the gene-loop formation between
the promoter and the terminator of RARB2.
(Lower panel) Cells bearing mutations
in genes encoding GTF2H5 p.[Leu21Pro];
[Arg56*], ERCC3 p.Phe99Ser, ERCC3
p.Thr119Pro, ERCC2 p.Arg112His, ERCC2
p.Gly602Asp, ERCC2 p.Arg683Trp, and
ERCC2.Arg722Trp differently disrupt the
RARB2 mRNA synthesis by deregulating
several transcriptional steps. When indi-
cated (), each variant specifically affects
(1) the formation of TFIIH, (2) its enzy-
matic activities (such as promoter opening
and pol II phosphorylation), (3) the recruit-
ment of NER factors, and (4) chromatin re-
modeling. ND stands for not determined.By investigating the mechanistic defects resulting from
mutations in genes encoding TFIIH subunits, the present
study intends to go deeper in the understanding of the
transcriptional role played by TFIIH at the cellular level.
Here, we document the involvement of TFIIH in pol II
phosphorylation, as well as in promoter unwinding, by
showing that TFIIH influences (1) the concomitant recruit-
ment of NER factors, (2) histone PTMs, (3) DNA breaks, (4)
DNA demethylation, and (5) gene-loop formation, all of
which are essential for accurate RNA synthesis (Figure 6).
Plasticity of TFIIH Recruitment at Activated Promoter
In bothWTand GTF2H5 (p8 or TTD-A) cells, we observed a
coordinated recruitment of all TFIIH subunits at the RARB2
promoter upon t-RA induction (Figure 2). Conversely, the
TFIIH subunits were no longer recruited together in cells
bearing mutations in ERCC3 and ERCC2. In particular, the
recruitment of the TFIIH subunits appeared disorganized
and took place over a longer period of time in ERCC2
(XPD)-p.Arg683Trp and ERCC2-p.Arg722Trp cells (Figures
2I2–2I4 and2J2–2J4). Theseobservations suggest that TFIIH
is not recruited as a whole in the presence of subunit vari-
ants that affect its integrity. Interestingly, this observation
illustrates the plasticity existing within TFIIH. Immuno-
fluorescence experiments have previously shown thatThe American Journal of Human GGTF2H5 is present in two distinct ki-
netic pools: one bound to TFIIH and
a free fraction that shuttles betweenthe cytoplasm and nucleus.29 Distinctmovements of TFIIH
subunits were also observed in Rift-Valley-fever-virus-in-
fected cells, in which the GTF2H2 (p44) and ERCC3 sub-
units were sequestered in nuclear filaments formed by the
viral protein NSs, whereas ERCC2 and GTF2H1 (p62) were
maintained in the cytoplasm and proteolyzed in the nu-
cleus, respectively.48,49 Moreover, it has been shown that
a dynamic composition of TFIIH occurs during NER, in
which the arrival of XPA at damaged DNA is subsequent
to the removal of the CAK sub-complex.50 This might
explain at least partially why CAK is also found free in
cellular extracts. TheERCC2subunit that canbe foundasso-
ciated with CAK51,52 might also be implicated in a complex
other than TFIIH, such as MMXD, a TFIIH-independent
ERCC2-MMS19 protein complex involved in chromosome
segregation.53 Although each subunit and/or sub-complex
can act independently, our data suggest that the activity
of TFIIH in pol-II-dependent transcription results from the
coordinated assembly of all its subunits.
TFIIH: A Platform to Recruit NER Factors during
Transcription
In some cases, failure in the integrity and/or formation of
TFIIH affects the enzymatic activities of this complex. In
particular, the ERCC3 p.Phe99Ser variant weakens theenetics 96, 194–207, February 5, 2015 203
interaction between ERCC3 and its regulatory GTF2HH4
(p52) subunit,37 disrupting the unwinding of activated
promoters, which is a key point during transcription
initiation. Similarly, the ERCC2 p.Arg683Trp and
p.Arg722Trp variants are known to weaken the binding
between ERCC2 and GTF2H2 (p44)32 and thus affect the
ability of CAK to phosphorylate pol II (Figure 5), a key
step for promoter escape. Accordingly, the transcriptional
defects associated with these ERCC2 mutations might
be more related to disruption of pol II phosphorylation
than to ERCC2 helicase deficiencies, reinforcing the
idea that ERCC2 helicase activity is not crucial for
transcription.
The gene-expression defects observed in cells bearing
mutations in ERCC2 and ERCC3 could not, however,
be solely explained by deficiencies in the enzymatic
activities of TFIIH. This is well illustrated by the fact that
ERCC3 p.Thr119Pro, ERCC2 p.Arg112His, and ERCC2
p.Gly602Asp did not affect basal transcription in an
in vitro context, whereas the expression of RARB2 was
defective in cells expressing the same variants (Figures
5A and 5B and Figures 2C1, 2G1, and 2H1). It is likely
that TFIIH variants might disturb the accurate recruitment
and/or positioning of components required for RNA syn-
thesis. Our results suggest that such recruitment of NER
factors is either incomplete or unsynchronized with the
general transcription machinery (Figure 2). In particular,
although ERCC5 stabilizes TFIIH and contributes to its
transactivation function, no simultaneous recruitment
of ERCC5, TFIIH, or the transcription machinery was
observed in ERCC2-p.Arg683Trp cells (Figures 2I2–2I4);
this might be related to the inability of ERCC5 to interact
with this aberrant form of ERCC2.46 Furthermore, our
results showed that the recruitment of NER factors
during transcription was differently affected depending
on the nature of the TFIIH variants. For instance, in
ERCC3-p.Thr119Pro cells, ERCC4 (XPF) was not detected
at the RARB2 promoter, on which the recruitment of all
basal transcription machinery, including TFIIH, was de-
regulated (Figures 2C2–2C4). However, in ERCC2-
p.Gly602Asp cells, TFIIH subunits and NER factors XPA
and ERCC5, but not ERCC4, were correctly recruited (Fig-
ures 2H2–2H4).
All together, our results show that TFIIH promotes the
recruitment of NER factors during transcription in a
manner different from that observed during NER. This
was well observed in GTF2H5 cells, in which the recruit-
ment of NER factors was normal during transcription
(Figures 2E2–2E4), whereas the GTF2H5 variant prevented
the recruitment of these factors during the NER pathway.54
In parallel, the recruitment of the NER factors during tran-
scription occurred normally in cells expressing ERCC2
p.Gly602Asp (Figures 2H2–2H4), which is known to pre-
vent damaged DNA from opening and the recruitment of
XPA in NER.32 The molecular aspects that differently influ-
ence the NER factors during transcription and DNA repair
are currently unclear.204 The American Journal of Human Genetics 96, 194–207, FebruaryTFIIH Orchestrates Chromatin Remodeling
According to the chromatin signatures observed in WT
cells, it seems that TFIIH variants alter chromatin remodel-
ing upon transcription by disturbing histone PTMs, DNA
demethylation, and gene-loop formation. These variants
prevent the establishment of permissive chromatin by
causing an intermediate environment that includes
euchromatic histone PTMs (H3K4me and H3K9ac) and
heterochromatin hallmarks (methylated DNA and
impaired gene-loop formation). In cells bearing mutations
in genes encoding TFIIH subunits, we observed that
H3K4me and H3K9ac occurred all along the time course
and that these modifications did not follow the pattern
of RNA synthesis (Figures 2 and 3). In most cases,
H3K9me was strongly reduced, suggesting that the defi-
ciency might particularly concern the methylation or de-
methylation process of the lysine residue. Furthermore,
mutations in ERCC3 and ERCC2 seem to profoundly alter
the tight connection that exists between histone PTMs
and the methylated status of DNA,55 which is well illus-
trated by the concomitant presence of H3K4me2 and
H3K9ac and the methylated DNA at the promoter
(Figure 3). Indeed, in addition to the histone PTM distur-
bance, the active DNA demethylation that occurs upon
transcription was abolished for all of cells bearing muta-
tions in ERCC2 and ERCC3. Several recent studies have
documented the involvement of DNA-repair factors,
including the endonuclease ERCC5, in the regulation
of DNA demethylation.11,56 We have notably correlated
DNA breaks involving ERCC5 with the 5mC sites that
were demethylated.35 Interestingly, ERCC3 p.Phe99Ser,
ERCC2 p.Gly602Asp, and ERCC2 p.Arg683Trp, which
affect ERCC5 recruitment, might contribute to the absence
of DNA breaks surrounding the RARB2 promoter (Figures
2B4, 2H4, and 2I4 and Figures 3B2, 3H2, and 3I2).
Conversely, DNA breaks were maintained in GTF2H5,
ERCC2-p.Arg112His, and ERCC2-p.Arg722Trp cells, in
which ERCC5 was normally recruited but without the ex-
pected co-detection of unmethylated DNA (Figures 3D2,
3D3, 3G2, 3G3, 3J2, and 3J3). DNA breaks therefore occur
even in the absence of DNA demethylation, indicating
that the presence of ERCC5 and the related cuts are neces-
sary but not sufficient to achieve such a process. It should
be noted that unmethylated DNA influences long-range
chromosomal interactions by being targeted by chromatin
organizers such as CTCF, as previously observed for the
imprinted Igf2-H19.57,58 Consequently, the defect of DNA
demethylation observed in cells bearing mutations in
genes encoding TFIIH subunits might contribute in part
to the absence of an inducible CTCF-dependent chromatin
loop between the promoter and the terminator of RARB2
(Figure 4).
Taken together, our data underline the key role of TFIIH
in the transcription process, in which its primary enzy-
matic activities are combined with the recruitment of
NER factors to further orchestrate events such as histone
PTMs, DNA breaks, DNAmethylation, and loop formation.5, 2015
Although each mutation in genes coding for TFIIH sub-
units specifically affects transcription, it seems that, in
addition to causing DNA-repair deficiencies, subtle differ-
ences in the transcription defects might contribute to the
phenotypic heterogeneity observed among XP, XP/CS,
and TTD individuals.Supplemental Data
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